| Amgen Switzerland AG - Blincyto 38.5 mcg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | | 65654 | | 01 | | Blincyto 38.5 mcg | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | | L01FX07 | | | | 25.02.2016 | | |
| | Composition | | Praeparatio cryodesiccata: blinatumomabum 38.5 µg, acidum citricum monohydricum, trehalosum dihydricum, lysini hydrochloridum, polysorbatum 80, natrii hydroxidum, pro vitro corresp. natrium 1.5 mg.
Solvens: acidum citricum monohydricum, lysini hydrochloridum, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 18.35 mg. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | | | | | | | | | | | BAG: Active Agent | Dose |
|---|
| | 38.5 mcg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Lysine Hydrochloride | | Sodium Hydroxide | | Polysorbatum 80 | | |
| |
| Solvens | | | | | | | | | | | | BAG: Active Agent | Dose |
|---|
| | 38.5 mcg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Lysine Hydrochloride | | Sodium Hydroxide | | Polysorbatum 80 |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 2302.39 | 2520.40 | A | SL | No |
|
|
